PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
25.06%
Net income growth above 1.5x ORCL's 16.52%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
32.18%
Some D&A expansion while ORCL is negative at -2.15%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-143.56%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-6.93%
Both cut yoy SBC, with ORCL at -9.00%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-37.44%
Both reduce yoy usage, with ORCL at -170.87%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-173.67%
Both yoy AR lines negative, with ORCL at -126.52%. Martin Whitman would suspect an overall sector lean approach or softer demand.
254.27%
Inventory growth well above ORCL's 60.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
318.12%
AP growth well above ORCL's 146.38%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
96.22%
Some yoy usage while ORCL is negative at -235.65%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-7.78%
Negative yoy while ORCL is 47.73%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-46.22%
Both yoy CFO lines are negative, with ORCL at -81.79%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-40.70%
Negative yoy CapEx while ORCL is 17.65%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-826.67%
Negative yoy acquisition while ORCL stands at 66.97%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
11.12%
Some yoy expansion while ORCL is negative at -17.08%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
20.42%
1.25-1.5x ORCL's 14.20%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
360.94%
We have some outflow growth while ORCL is negative at -26.30%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
77.79%
Investing outflow well above ORCL's 10.63%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
41.20%
Debt repayment well below ORCL's 100.00%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
-42.36%
Negative yoy issuance while ORCL is 68.42%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
3.43%
Buyback growth at 75-90% of ORCL's 4.55%. Bill Ackman would call for more share repurchases if undervaluation is evident, to match competitor’s approach.